Biocon tanks 4% as USFDA defers decision on Avastin biosimilar applicationBiocon's arm Biocon Biologics and Mylan, a subsidiary of Viatris Inc, have been informed by the USFDA of a deferred action on the BLA for M...
28 Dec, 2020, 09.56 AM IST
USFDA informs Biocon Biologics, Mylan of deferred action on Avastin biosimilar license application"To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the standard revie...
25 Dec, 2020, 01.55 PM IST
Dr Reddy's launches Roche's Avastin biosimilar in IndiaThe launch of Versavo is another step in that journey and helps in strengthening the company's oncology portfolio.
19 Aug, 2019, 01.49 PM IST
Roche and Cipla tie up to market anti cancer drugsRoche said this partnership will also enable it to focus on bringing new, transformative medicines to patients in India.
28 Feb, 2018, 08.54 AM IST
Biocon shares gains on cancer drug launchA biosimilar is a near copy of an original complex biologic drug.
23 Nov, 2017, 06.51 PM IST
Intas launches biosimilar Bevacizumab with aggressive pricingBiosimilar drugs are the follow on versions of biologic drugs which are composed of sugars, proteins, nucleic acids or complex combinations...
04 Oct, 2017, 08.40 PM IST
Reliance Lifesciences launches world's first biosimilar used to treat advanced cancersIn 2014, Reliance had entered into a similar arrangement with Torrent Pharma to sell copies of three drugs -- rituximab, adalimumab and cet...
10 Jun, 2016, 03.05 AM IST
Delhi High Court asks Roche to explain lawsuit over Avastin copyRoche, which invented the drug and markets it under the blockbuster brand ‘Avastin’, has argued that Hetero’s drug is not a biosimilar to b...
24 May, 2016, 09.39 PM IST
Roche’s reputation at stake if Avastin biosimilar approved without trial: Kapil SibalThe judge asked the company to submit a compilation of judgments highlighting the protection given to drug innovators to support its call.
21 May, 2016, 01.14 PM IST
Roche moves court to block copies of cancer drug Avastin, A La HerceptinRoche has challenged the regulator and pleaded to block the approvals of the drugs under review, ET learned from highly placed legal source...
17 May, 2016, 02.33 AM IST
Indian drug regulator backs off over use of Roche’s AvastinThe Drug Controller General of India has passed an order removing an alert notice for the use of Roche’s Avastin (bevacizumab) injection to...
12 Mar, 2016, 11.49 PM IST
Roche begins probe into Avastin use for eye ailmentsRoche has initiated an internal investigation following reports the it had been used in certain eye ailments and damaged the vision of 15 p...
23 Jan, 2016, 06.07 AM IST
- Cipla to partner Chinese co in selling Roche, Amgen drug clones
Cipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...
17 Jun, 2010, 02.44 AM IST
- Swiss drugmaker Roche completes Genentech takeover
Swiss pharmaceutical giant Roche said it has completed its $46.8 billion takeover of California-based biotech firm Genentech.
26 Mar, 2009, 01.19 PM IST
- Genentech tells shareholders to reject Roche bid
Genentech Inc. says its shareholders should reject a hostile buyout bid from Swiss drugmaker Roche.
24 Feb, 2009, 04.23 AM IST
- Roche makes 'cheaper' bid for Genentech
Roche Holding AG lowered the acquisition price by 2.8% and took the offer for the US cancer-drug developer directly to shareholders.
31 Jan, 2009, 12.26 AM IST
- Roche files for Avastin to treat breast cancer in Europe
Swiss drugmaker Roche has filed its Avastin drug for use in previously untreated advanced breast cancer in Europe, the company said on Mond...
11 Jul, 2006, 12.30 AM IST